GluK2 is a target for gene therapy in drug-resistant Temporal Lobe Epilepsy https://www.biorxiv.org/content/10.1101/2023.04.13.536748v1?med=mas
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.